Cargando…
Prevalence and Prognosis of Lynch Syndrome and Sporadic Mismatch Repair Deficiency in Endometrial Cancer
BACKGROUND: Standard screening of endometrial cancer (EC) for Lynch syndrome (LS) is gaining traction; however, the prognostic impact of an underlying hereditary etiology is unknown. We established the prevalence, prognosis, and subsequent primary cancer incidence of patients with LS-associated EC i...
Autores principales: | Post, Cathalijne C B, Stelloo, Ellen, Smit, Vincent T H B M, Ruano, Dina, Tops, Carli M, Vermij, Lisa, Rutten, Tessa A, Jürgenliemk-Schulz, Ina M, Lutgens, Ludy C H W, Jobsen, Jan J, Nout, Remi A, Crosbie, Emma J, Powell, Melanie E, Mileshkin, Linda, Leary, Alexandra, Bessette, Paul, Putter, Hein, de Boer, Stephanie M, Horeweg, Nanda, Nielsen, Maartje, van Wezel, Tom, Bosse, Tjalling, Creutzberg, Carien L |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8418420/ https://www.ncbi.nlm.nih.gov/pubmed/33693762 http://dx.doi.org/10.1093/jnci/djab029 |
Ejemplares similares
-
Molecular Classification Predicts Response to Radiotherapy in the Randomized PORTEC-1 and PORTEC-2 Trials for Early-Stage Endometrioid Endometrial Cancer
por: Horeweg, Nanda, et al.
Publicado: (2023) -
Prognostic refinement of NSMP high-risk endometrial cancers using oestrogen receptor immunohistochemistry
por: Vermij, Lisa, et al.
Publicado: (2023) -
HER2 Status in High-Risk Endometrial Cancers (PORTEC-3): Relationship with Histotype, Molecular Classification, and Clinical Outcomes
por: Vermij, Lisa, et al.
Publicado: (2020) -
Selecting Adjuvant Treatment for Endometrial Carcinoma Using Molecular Risk Factors
por: Wortman, Bastiaan G., et al.
Publicado: (2019) -
Prognostic Significance of POLE Proofreading Mutations in Endometrial Cancer
por: Church, David N., et al.
Publicado: (2014)